Protective Immunity in Mice with Whole Body of Echinococcus granulosus
Authors
Abstract:
Despite the establishment of extensive and successful control programmes in some countries or regions, Echinococcus granulosus still has a very wide geographical distribution. Mature E. granulosus (n = 120) obtained from Parasitology Department, School of Veterinary Medicine, Ferdowsi University of Mashhad (Iran). Soluble protein of whole body of parasite was prepared by freeze-thawing in liquid nitrogen and at 42ºC for three times. The sample was homogenized in a blender, sonicated at 110 V, 170 W for 3 times for 15 s each and then centrifuged at 10,000 ×g for 15 min. Final yield was kept in -20ºC. Ten mice were randomly divided into 2 groups of 5. Each mouse in test group was vaccinated subcutaneously with 100 µg (100 µl) of whole body of E. granulosus plus 100 µl of Freund’s complete adjuvant (FCA), respectively. Mice in control group were vaccinated with adjuvant in PBS. Second vaccination was conducted after four weeks with the same preparation except that FCA was replaced by Freund’s incomplete adjuvant (FIA). Three weeks after the second vaccination, each mouse was challenged with 2000 protoscolices, intraperitoneally. Mouse autopsy was carried out eight months post challenge. Our results show that none of the vaccinated mice with the whole body of E. granulosus had cysts that indicate 100% protective immunity.
similar resources
protective immunity in mice with whole body of echinococcus granulosus
despite the establishment of extensive and successful control programmes in some countries or regions, echinococcus granulosus still has a very wide geographical distribution. mature e. granulosus (n = 120) obtained from parasitology department, school of veterinary medicine, ferdowsi university of mashhad (iran). soluble protein of whole body of parasite was prepared by freeze-thawing in liqui...
full textImmunization of lambs with whole body Echinococcus granulosus
We conducted this study to determine the level of immunity after vaccination of lambs with whole bodyEchinococcus granulosus. To do so, 200 mature E. granulosus parasites, which were kept in 10% formalinefor 8 months, were obtained from the Department of Parasitology, School of Veterinary Medicine, FerdowsiUniversity of Mashhad. The soluble protein of the parasite was prepared. The sample was h...
full textimmunization of lambs with whole body echinococcus granulosus
we conducted this study to determine the level of immunity after vaccination of lambs with whole bodyechinococcus granulosus. to do so, 200 mature e. granulosus parasites, which were kept in 10% formalinefor 8 months, were obtained from the department of parasitology, school of veterinary medicine, ferdowsiuniversity of mashhad. the soluble protein of the parasite was prepared. the sample was h...
full textAntibody response against hydatid fluid, protoscolex and whole body of Echinococcus granulosus antigens in lambs
In this study, the immunogenicity of three types of antigens (hydatid fluid, protoscolices and whole body of E. granulosus) was investigated in lambs by ELISA. Sixteen 4–6-month-old lambs of mixed sexes were divided into 4 groups of 4 lambs (three immunized and one control group). Twelve lambs as immunized groups received 2 mg of hydatid fluid, protoscolices and whole body of E. granulosus ant...
full textTrials to induce protective immunity in mice and sheep by application of protoscolex and hydatid fluid antigen or whole body antigen of Echinococcus granulosus.
In the current study, soluble proteins prepared from 200 mature Echinococcus granulosus and protoscolices of sheep hydatid cysts were applied to immunize sheep and mice respectively. The samples were mechanically homogenized in a blender, sonicated and the final yield was maintained at -20 degrees C until analysis. Hydatid fluid was isolated from liver or lung of sheep under sterile conditions....
full textBALB/c Mice Immunity to Hydatidosis Induced by In-vitro Reared Echinococcus granulosus Adult Worm Antigens
Background: Echinococcosis is a zoonotic parasitic disease caused by the larval stage of Echinococcus granulosus. Several native and recombinant antigens, derived from different stages of E. granulosus life cycle, have been used for vaccine trials. In vitro reared adult worms are good candidates for vaccination as they do not produce fertile egg/s and do not have any risk of contamination for r...
full textMy Resources
Journal title
volume 10 issue 1
pages 51- 55
publication date 2006-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023